Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Ann Neurol. 2022 May 28;92(2):304–321. doi: 10.1002/ana.26381

Table 2.

Phenotypic features of ENTPD1-related neurological disease

Clinical features This cohort Prior publications All affected individuals

Early childhood age of onset (HP:0011463) 22/22 9/9 31/31
Developmental delay/intellectual disability (HP:0012758) 22/22 9/9 31/31
Progressive spastic paraplegia (HP:0007020) 22/22 9/9 31/31
Gait impairment (HP:0002355) 22/22 9/9 31/31
Abnormal reflexes (HP:0031826) 11/22 9/9 20/31
Dysarthria (HP:0001260) 13/22 7/9 20/31
Developmental regression (HP:0002376) 15/22 3/9 18/31
Dysmorphic facies (HP:0001999) 16/22 NR 16/31
Weakness (HP:0001324) 14/22 3/9 17/31
Behavioural abnormalities (HP:0000708) 10/22 5/9 15/31
Cerebral hypomyelination (HP:0006808) 11/18 3/8 14/26
Neuropathy (HP:0009830) 13/22 NR 13/31
Hand and foot deformities (HP:0001155 and 0001760) 8/22 3/9 11/31
Hypotonia (HP:0001252) 5/22 NR 5/31
Cataracts (HP:0000518) 3/22 1/9 4/31
Epilepsy (HP:0001250) 2/22 NR 2/31
Scoliosis (HP:0002650) 3/22 NR 3/31

NR-not reported